Understanding the age spectrum of respiratory syncytial virus associated hospitalisation and mortality burden based on statistical modelling methods: a systematic …

B Cong, I Dighero, T Zhang, A Chung, H Nair, Y Li - BMC medicine, 2023 - Springer
Background Statistical modelling studies based on excess morbidity and mortality are
important for understanding RSV disease burden for age groups that are less frequently …

Epidemiology of respiratory infections during the COVID-19 pandemic

N Principi, G Autore, G Ramundo, S Esposito - Viruses, 2023 - mdpi.com
To face the COVID-19 outbreak, a wide range of non-pharmaceutical interventions (NPIs)
aimed at limiting the spread of the virus in communities, such as mask-wearing, hand …

[HTML][HTML] Impact of nirsevimab prophylaxis on paediatric respiratory syncytial virus (RSV)-related hospitalisations during the initial 2023/24 season in Luxembourg

C Ernst, D Bejko, L Gaasch, E Hannelas… - …, 2024 - eurosurveillance.org
After Luxembourg introduced nirsevimab immunisation against respiratory syncytial virus
(RSV), estimated neonatal coverage was 84%(1,277 doses/1,524 births) in 2023. That year …

[HTML][HTML] Genetic diversity and its impact on disease severity in respiratory syncytial virus subtype-A and-B bronchiolitis before and after pandemic restrictions in Rome

A Pierangeli, R Nenna, M Fracella, C Scagnolari… - Journal of Infection, 2023 - Elsevier
Objectives To scrutinize whether the high circulation of respiratory syncytial virus (RSV)
observed in 2021–2022 and 2022–2023 was due to viral diversity, we characterized RSV-A …

All-cause and pathogen-specific lower respiratory tract infection hospital admissions in children younger than 5 years during the COVID-19 pandemic (2020–22) …

A Izu, MC Nunes, F Solomon, V Baillie… - The Lancet Infectious …, 2023 - thelancet.com
Background Non-pharmaceutical interventions affected the circulation of and illness due to
endemic respiratory pathogens during the COVID-19 pandemic. We investigated the …

Respiratory syncytial virus surge in 2022 caused by lineages already present before the COVID‐19 pandemic

M Redlberger‐Fritz, DN Springer… - Journal of Medical …, 2023 - Wiley Online Library
In 2022, Austria experienced a severe respiratory syncytial virus (RSV) epidemic with an
earlier‐than‐usual start (Weeks 35/2021–45/2022) and increased numbers of pediatric …

Efficacy and safety of Respiratory Syncytial Virus (RSV) prefusion F protein vaccine (RSVPreF3 OA) in older adults over 2 RSV seasons

MG Ison, A Papi, E Athan, RG Feldman… - Clinical Infectious …, 2024 - academic.oup.com
Background The adjuvanted RSV prefusion F protein–based vaccine (RSVPreF3 OA) was
efficacious against RSV-related lower respiratory tract disease (RSV-LRTD) in≥ 60-years …

Mycoplasma pneumoniae epidemic in Denmark, October to December, 2023

AC Nordholm, B Søborg, P Jokelainen… - …, 2024 - eurosurveillance.org
We report a surge of patients, especially children and adolescents, with respiratory disease
caused by Mycoplasma pneumoniae in Denmark since October 2023. While the surge has …

Respiratory syncytial virus infection in the modern era

M Ludlow - Current opinion in infectious diseases, 2023 - journals.lww.com
Respiratory syncytial virus infection in the modern era : Current Opinion in Infectious
Diseases Respiratory syncytial virus infection in the modern era : Current Opinion in …

Clinical, genomic, and immunological characterization of RSV surge in Sydney, Australia, 2022

GJ Walker, CSP Foster, A Sevendal… - …, 2024 - publications.aap.org
OBJECTIVES The 2022 seasonal respiratory syncytial virus (RSV) epidemic in Sydney,
Australia saw an unprecedented number of RSV detections. We aimed to characterize …